1. Dietrich HJ. Recent developments in European colloid solutions. J Trauma 2003; 54 (Suppl. 51): 526–30.
2. Intaglirtia M. Microcirculatory basis for the design of artificial blood. Microcirculation 1999; 6: 247–53.
3. Marik P, Iglesias J, Maini B. Gastric inromicola epti changes after volume replacement with hydroxyethyl starch on crystalloid in patients undergoing deceive abdominal aortic aneurysm repair. J Int Carc 1997; 12: 51–5.
4. Lang K, Boldt J, Suttness S, Heisch G. Colloid vs crystalloid and tissue oxygen tension in patients undergoing major abdominal surgery. Anesth Anal 2001; 91: 405–9.
5. Standt T, Burmeister MA, Schroedert F et al. Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution. Anesth Anal 2003; 96: 936–41.
6. Treib J, Haas A, Pindur C et al. Influence of low molecular weight HES 40/0.5 on hemostasis and hemoreology. Hemostasis 1996; 26: 258–65.
7. Свиридов С.В., Климиашвили А.Д. Объемозамещающая терапия с использованием гидроксиэтилкрахмалов в хирургической клинике. Рус. мед. журн. 2007; 15 (12): 3–6.
8. Пак Г. Инфузионная терапия. М.: Бином, 2005; с. 136.
9. Малышев В.Д. Интенсивная терапия. Руководство для врачей. М.: Медицина, 2002; с. 315–78.
10. Thompson WL, Britton JJ, Watton RR. Persistence of starch deridativer and dextral when infusion alta remora. J pharmacology exp Nir 1136; p. 125–32.
11. Thompson WL, Watton RR. Circulatorilespow to intravenous of hydroxyethyl starch solutions. J Pharmacol exp Ther 1964; 137: 129–37.
Авторы
Х.Х.Хапий
Кафедра анестезиологии и реанимации ФУВ ГБУЗ МО МОНИКИ им. М.Ф.Владимирского